Cargando…
Pathogen inactivation and removal procedures used in the production of intravenous immunoglobulins
Patients with immunodeficiencies or some types of autoimmune diseases rely on a safe therapy with intravenous immunoglobulins (IVIGs) manufactured from human plasma, the only available source for this therapeutic. Since plasma is predisposed to contamination by a variety of blood-borne pathogens, as...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
The International Association for Biologicals. Published by Elsevier Ltd.
2007
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7129354/ https://www.ncbi.nlm.nih.gov/pubmed/16581263 http://dx.doi.org/10.1016/j.biologicals.2006.01.002 |